Healthy Lifestyles and Quality of Life in Women With Breast Cancer
NCT ID: NCT04379908
Last Updated: 2023-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
801 participants
OBSERVATIONAL
2017-11-07
2019-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breast Cancer and Quality of Life
NCT01661816
Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women
NCT03918668
Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery
NCT04616300
Health Status of Women With Breast Cancer
NCT03761940
Multicenter Study to Evaluate a Systematized Communication Model for Breast Cancer Patients
NCT05837533
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Survivors will be re-surveyed to assess tobacco, alcohol, diet, obesity and health-related quality of life, using a specific questionnaire witch contains the following information:
* Sociodemographic information.
* Anthropometric data (weight, height).
* Clinical and gynecological data.
* Assessment of lifestyle habits: including tobacco consumption and diet.
* Physical activity questionnaire, with the International Physical Activity Questionnaire (IPAQ).
* Questionnaire to know the preference of patients on receiving information about their treatment in physical exercise.
* General Short Form-36 (SF36) quality of life questionnaire already used at the time of diagnosis.
* Specific Fatigue and Quality of Life Questionnaires: Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B) and Functional Assessment of Cancer Therapy - Fatigue (FACT-F).
* Coping questionnaires: COPE-28 and Brief Resilience Scale (BRS).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable and willing women to provide their written informed consent. If the patient has died, the biological sample and clinical data may be analyzed in those cases in which there is no express opposition from the patient or her relatives for participation in this type of study. The document of previous instructions will be consulted and, failing that, the criteria of the closest relative of the deceased will be recorded.
* Capable and willing women to complete the questionnaires provided in the study (except deceased).
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asociación Española contra el Cáncer
OTHER
Spanish Breast Cancer Research Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Study Director
Role: STUDY_DIRECTOR
Instituto de Salud Carlos III
Study Director
Role: STUDY_DIRECTOR
Hospital General Universitario Gregorio Marañón
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Mutua de Terrassa
Terrassa, Barcelona, Spain
Consorci Sanitari de Terrassa
Terrassa, Barcelona, Spain
Complejo Hospitalario Universitario A Coruña (CHUAC)
A Coruña, Galicia, Spain
Hospital Universitario Fundación Alcorcón
Alcorcón, Madrid, Spain
Centro Oncológico de Galicia
A Coruña, , Spain
Hospital General Universitario de Alicante
Alicante, , Spain
Hospital Universitario Virgen de los Lirios
Alicante, , Spain
Hospital Clinic i Provincial
Barcelona, , Spain
Hospital Universitario de Burgos
Burgos, , Spain
Hospital Puerta del Mar
Cadiz, , Spain
ICO de Girona, Hospital Dr. Josep Trueta
Girona, , Spain
Complejo Hospitalario de Jaén
Jaén, , Spain
Hospital Clínico San Carlos
Madrid, , Spain
Hospital Universitario Virgen del Rocío
Seville, , Spain
Hospital Universitario Virgen de la Salud
Toledo, , Spain
Instituto Valenciano de Oncología
Valencia, , Spain
Hospital Clinico Universitario de Valencia
Valencia, , Spain
Hospital Universitario Miguel Servet
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lope V, Guerrero-Zotano A, Ruiz-Moreno E, Bermejo B, Antolin S, Montano A, Baena-Canada JM, Ramos Vazquez M, Fernandez de Larrea-Baz N, Chacon JI, Garcia-Saenz JA, Olier C, Munoz M, Anton A, Sanchez Rovira P, Arcusa Lanza A, Gonzalez S, Oltra A, Brunet J, Gavila Gregori J, Martinez MT, Calvo L, Rosell L, Bezares S, Pastor-Barriuso R, Perez-Gomez B, Martin M, Pollan M. Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study. Cancers (Basel). 2022 Sep 27;14(19):4705. doi: 10.3390/cancers14194705.
Related Links
Access external resources that provide additional context or updates about the study.
Spanish Breast Cancer Research Group (GEICAM) is a Spanish Breast Cancer Research Group
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Health-EpiGEICAM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.